Neuland Laboratories Limited
Neuland Laboratories Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: NEULANDLAB and BSE: 524558 (ISIN INE794A01010).
It has a market capitalisation of ₹24,795 crore, a last close of ₹19,220 on 2026-10-19, a one-year return of 18.1%.
Valuation: a price-to-earnings ratio of 61.85x, a price-to-book ratio of 13.23x, a dividend yield of 0.2%.
Profitability: return on equity of 21.4%, return on capital employed of 26.1%, an operating margin of 32.2%.
Growth: sales growth of 19.3% a year over three years, net profit growth of 30.6% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.10x, promoter holding of 32.3%.
| Metric | Value |
|---|---|
| Market capitalisation | 24,795 |
| Last close | ₹19,220 |
| P/E (TTM) | 61.85x |
| P/B | 13.23x |
| Dividend yield | 0.2% |
| ROE (FY) | 21.4% |
| ROCE (FY) | 26.1% |
| Operating margin (TTM) | 32.2% |
| Sales growth, 3-year CAGR | 19.3% |
| Profit growth, 3-year CAGR | 30.6% |
| Debt / equity | 0.10x |
| Promoter holding | 32.3% |
| 1-year return | 18.1% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means